MTD

Mettler-Toledo International
D

MTD

Arincen80/100B

Mettler-Toledo International financials

Yes. Mettler-Toledo International earned 934.07M USD of net income over the last twelve months, 22.2% of its revenue. It made a profit in 28 of its 29 fiscal years since 1997. Its last loss was in fiscal year 1997.

Revenue (TTM)
4.20B USD
Net income (TTM)
934.07M USD
Free cash flow (TTM)
870.57M USD
Cash and short-term investments
52.24M USD
Total debt
2.02B USD
Shareholders' equity
77.66M USD

Cash, debt and equity as of 30 Sept 2026.

Mettler-Toledo International earnings

Next earnings · Q4 FY2026
EPS estimate
14.94 USD
Revenue estimate
1.18B USD
Last quarter · Q3 FY2026
EPS12.57Beat +3.6%Revenue1.09BBeat +2.1%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q4 FY202614.94——+11.83%1.18B——+4.85%
Q3 FY202612.1312.57+3.63%+12.74%1.07B1.09B+2.14%+6.27%
Q2 FY202610.8511.46+5.62%+13.58%1.03B1.03B-0.04%+4.48%
Q1 FY20268.718.91+2.30%+8.79%943.14M947.13M+0.42%+7.17%
Q4 FY202512.8013.36+4.37%+7.66%1.10B1.13B+2.31%+8.10%
Q3 FY202510.6611.15+4.60%+9.21%997.29M1.03B+3.25%+7.87%
Q2 FY20259.6010.09+5.10%+4.56%957.65M983.22M+2.67%+3.85%

Mettler-Toledo International growth and profitability

Full income statement
Revenue (TTM)
4.20B USD
Net income (TTM)
934.07M USD
Gross margin
59.00%
Operating margin
28.45%
Net margin
22.25%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY20254.03B+3.98%869.19M+0.70%59.37%27.78%21.59%1.24B-0.58%
FY20243.87B+2.22%863.14M+9.43%58.17%29.11%22.29%1.25B+4.12%
FY20233.79B-3.35%788.78M-9.60%57.26%28.50%20.82%1.20B-3.10%
FY20223.92B+5.43%872.50M+13.46%57.19%28.73%22.26%1.24B+12.37%
FY20213.72B+20.51%768.99M+27.58%56.71%26.76%20.68%1.10B+24.93%

How Mettler-Toledo International makes its money

Laboratory products and services2.24B 55.7%
Industrial products and services1.58B 39.2%
Retail products and services205.94M 5.1%
Revenue4.03B 100.0%
Cost of revenue1.64B 40.6%
Gross profit2.39B 59.4%
Research and development199.37M 5.0%
Selling and administration998.31M 24.8%
Other operating expenses74.47M 1.8%
Operating income1.12B 27.8%
Tax179.72M 4.5%
Other expense69.58M 1.7%
Net income869.19M 21.6%

FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.

Mettler-Toledo International revenue breakdown

By product

FY2025
Laboratory products and services: 55.7%Industrial products and services: 39.2%Retail products and services: 5.1%55.7%Laboratory products and services39.2%Industrial products and services5.1%Retail products and services
SegmentRevenueShare of revenueChange on the year
Laboratory products and services2.24B55.7%+2.5%
Industrial products and services1.58B39.2%+6.0%
Retail products and services205.94M5.1%+4.9%

By region

FY2025
100.0%Asia
RegionRevenueShare of revenueChange on the year
Asia1.19B100.0%+1.7%

Operating and free cash flow

Full cash flow statement
Operating cash flow Free cash flow
Fiscal yearOperating cash flowFree cash flow
FY2025955.77M848.65M
FY2024968.35M864.45M
FY2023965.87M860.55M
FY2022859.07M737.83M
FY2021908.83M801.25M
FY2020724.70M632.21M
FY2019603.45M506.11M
FY2018565.01M422.28M
FY2017516.33M388.90M
FY2016443.08M319.12M

Mettler-Toledo International financial health

Full balance sheet
Cash and short-term investments
52.24M USD
Total debt
2.02B USD
Net cash
-1.97B USD
Free cash flow (TTM)
870.57M USD
Current ratio
1.10
Debt to equity
26.06
Piotroski score
8 / 9
Altman Z-score
11.81

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY202566.89M2.34B848.65M
FY202459.36M2.13B864.45M
FY202369.81M2.20B860.55M
FY202295.97M2.13B737.83M
FY202198.56M1.80B801.25M

Assets, liabilities and equity

Total assets Total liabilities Shareholders' equity
Fiscal yearTotal assetsTotal liabilitiesShareholders' equity
FY20253.71B3.74B-23.64M
FY20243.24B3.37B-126.89M
FY20233.36B3.51B-149.94M
FY20223.49B3.47B24.79M
FY20213.33B3.16B171.42M
FY20202.81B2.53B282.68M
FY20192.79B2.37B420.78M
FY20182.62B2.03B590.06M
FY20172.55B2.00B547.28M
FY20162.17B1.73B434.94M

Mettler-Toledo International valuation

Price to earnings ratio (TTM)
37.17
Forward P/E (FY2026)
36.01
Price to sales (TTM)
8.15
Price to book
440.40
EV / EBITDA (TTM)
27.17

Capital structure

Market capitalization
34.20B USD
+
Total debt
2.02B USD
−
Cash and short-term investments
52.24M USD
=
Enterprise value
36.17B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)29.54————
FY2027 (est.)32.4929.54———
FY2026 (est.)36.0132.49———
Now (TTM)37.1732.918.15440.4027.17
FY202533.0629.207.14-1,215.7124.95
FY202430.0929.006.71-204.6622.43
FY202333.6030.047.00-176.7523.84
FY202237.2637.218.291,311.2927.88
FY202151.0443.4110.56229.0037.14

Mettler-Toledo International against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: Illumina, Labcorp Holdings, Quest Diagnostics, IQVIA Holdings, Waters, and Agilent Technologies, the US Medical - Diagnostics & Research companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Above its median37.2
    23.852.6
  • Gross marginHighest in 5 years59.4%
    56.7%59.4%
    Against its peers: 2 of 7Peers' median 42.9%
  • Operating marginBelow its median27.8%
    26.8%29.1%
    Against its peers: 2 of 7Peers' median 17.2%
  • Net marginAt its median21.6%
    20.7%22.3%
    Against its peers: 1 of 7Peers' median 13.9%
  • Free cash flow marginBelow its median21.1%
    18.8%22.7%
    Against its peers: 2 of 7Peers' median 14.6%
  • Revenue growthAt its median4.0%
    -3.4%20.5%
    Against its peers: 6 of 7Peers' median 6.9%
  • EPS growthBelow its median3.9%
    -6.5%31.6%
    Against its peers: 4 of 6Peers' median 4.7%
  • Debt to EBITDAHighest in 5 years1.89×
    1.63×1.89×
    Against its peers: 4 of 7Peers' median 2.49×
  • Current ratioAbove its median1.14
    1.021.20
    Against its peers: 5 of 7Peers' median 1.58

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

Mettler-Toledo International ownership

Institutions
102.01%
Institutional holders
831 (-10)
Free float
99.45%

Who owns the shares

Institutions 100.0% Others 0.0%
As of 30 Jun 2026

Shares free to trade

Free float 19.78M shares ·99.4% Closely held 109.60K shares ·0.6%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q4 202602435.00870.00
Q3 2026054.27K8.51K
Q2 2026005.08K0.00
Q1 202601980.001.60K

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY202520.61M20.67M-3.04%
FY202421.22M21.32M-2.96%
FY202321.85M21.97M-3.29%
FY202222.49M22.72M-3.15%
FY202123.13M23.46M-3.06%

Common questions about Mettler-Toledo International's financials

Source: Financial Modeling PrepVerified against SEC filings